Literature DB >> 9385689

Prevalence of symptomatic bronchiectasis in patients with rheumatoid arthritis.

J Allain1, A Saraux, C Guedes, I Valls, V Devauchelle, P Le Goff.   

Abstract

OBJECTIVE: To evaluate the prevalence of symptomatic bronchiectasis in patients with rheumatoid arthritis.
METHODS: Cross-sectional retrospective study of 453 rheumatoid arthritis patients. All patients completed a questionnaire designed to detect manifestations of bronchiectasis and had a chest film taken. Computed tomography of the chest was performed in those patients whose chest film was normal.
RESULTS: Thirteen patients (2.9%), all female, had symptoms that met Walker's criteria for definite (n = 7) or probable (n = 6) bronchiectasis. Symptom onset was during childhood or adolescence in 69% of cases and antedated the first symptoms of rheumatoid arthritis in all patients but one. Six of the 13 patients (46%) had chest film abnormalities suggestive of bronchiectasis, and three of the remaining seven patients had abnormal computed tomography findings, yielding a total of nine cases of bronchiectasis confirmed by imaging studies among the 13 patients with suggestive symptoms (69%). This proportion rose to 90% when the three patients who failed to come to their computed tomography appointment were excluded.
CONCLUSION: Using a methodological approach similar to that previously used by pneumologists, we found a 2.9% prevalence of symptomatic bronchiectasis in a population of hospitalized rheumatoid arthritis patients, which is higher than the 0.03% prevalence previously reported in the population at large.

Entities:  

Mesh:

Year:  1997        PMID: 9385689

Source DB:  PubMed          Journal:  Rev Rhum Engl Ed        ISSN: 1169-8446


  8 in total

Review 1.  Prevalence and risk factors of bronchiectasis in rheumatoid arthritis: A systematic review and meta-analysis.

Authors:  Lily W Martin; Lauren C Prisco; Weixing Huang; Gregory McDermott; Nancy A Shadick; Tracy J Doyle; Jeffrey A Sparks
Journal:  Semin Arthritis Rheum       Date:  2021-08-20       Impact factor: 5.431

Review 2.  A Closer Look at the Role of Anti-CCP Antibodies in the Pathogenesis of Rheumatoid Arthritis-Associated Interstitial Lung Disease and Bronchiectasis.

Authors:  Tanjila Khan; Ricardo J Jose; Elisabetta A Renzoni; Maria Mouyis
Journal:  Rheumatol Ther       Date:  2021-08-27

Review 3.  Severe bronchiectasis.

Authors:  Brian M Morrissey; Samuel J Evans
Journal:  Clin Rev Allergy Immunol       Date:  2003-12       Impact factor: 8.667

4.  Bronchiectasis is a Model for Chronic Bacterial Infection Inducing Autoimmunity in Rheumatoid Arthritis.

Authors:  Anne-Marie Quirke; Elizabeth Perry; Alison Cartwright; Clive Kelly; Anthony De Soyza; Paul Eggleton; David Hutchinson; Patrick J Venables
Journal:  Arthritis Rheumatol       Date:  2015-09       Impact factor: 10.995

Review 5.  Lung Involvements in Rheumatic Diseases: Update on the Epidemiology, Pathogenesis, Clinical Features, and Treatment.

Authors:  You-Jung Ha; Yun Jong Lee; Eun Ha Kang
Journal:  Biomed Res Int       Date:  2018-05-08       Impact factor: 3.411

Review 6.  Primary care implications of the British Thoracic Society Guidelines for bronchiectasis in adults 2019.

Authors:  Kevin Gruffydd-Jones; Duncan Keeley; Vikki Knowles; Ximena Recabarren; Alex Woodward; Anita L Sullivan; Michael R Loebinger; Karen Payne; Alex Harvey; Lizzie Grillo; Sally A Welham; Adam T Hill
Journal:  NPJ Prim Care Respir Med       Date:  2019-06-27       Impact factor: 2.871

7.  Rheumatoid arthritis-associated autoantibodies in non-rheumatoid arthritis patients with mucosal inflammation: a case-control study.

Authors:  Koen M J Janssen; Menke J de Smit; Elisabeth Brouwer; Fenne A C de Kok; Jan Kraan; Josje Altenburg; Marije K Verheul; Leendert A Trouw; Arie Jan van Winkelhoff; Arjan Vissink; Johanna Westra
Journal:  Arthritis Res Ther       Date:  2015-07-09       Impact factor: 5.156

Review 8.  The Role of the Immune Response in the Pathogenesis of Bronchiectasis.

Authors:  Paul T King
Journal:  Biomed Res Int       Date:  2018-03-18       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.